Treximet
NDC Package 0173-0750-62

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Treximet is this combination product contains two ingredients: naproxen and sumatriptan. Marketed by Glaxosmithkline Llc, this product is identified by NDC 0173-0750 and is authorized under FDA application NDA021926.

Identification & Billing

NDC Package Code
0173-0750-62
Package Description
1 TABLET, FILM COATED in 1 BOTTLE
Product Code
0173-0750
11-Digit Billing Format
00173075062

Clinical Specifications

Proprietary Name
Treximet
Dosage Form
-
Usage Information
This combination product contains two ingredients: naproxen and sumatriptan. It helps to relieve headache, pain, and other migraine symptoms (including nausea, vomiting, sensitivity to light/sound) in adults and in children 12 years or older. Prompt treatment helps you return to your normal routine and may decrease your need for other pain medications. Naproxen is known as a nonsteroidal anti-inflammatory drug (NSAID). It is used to relieve pain. Sumatriptan belongs to a class of drugs called triptans. It affects a certain natural substance (serotonin) that causes narrowing of blood vessels in the brain. It may also relieve pain by affecting certain nerves in the brain. This medication does not prevent future migraines or lessen how often you get migraine attacks.

Regulatory & Marketing

Labeler Name
Glaxosmithkline Llc
FDA Application #
NDA021926
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
04-25-2008
End Marketing Date
07-31-2018
Listing Expiration
07-31-2018
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0173-0750). Click a package code to view its specific billing and regulatory data.

0173-0750-00
9 TABLET, FILM COATED in 1 CONTAINER
0173-0750-49
9 TABLET, FILM COATED in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0173-0750-62 identifies a specific commercial package of 1 tablet, film coated in 1 bottle of Treximet, labeled by Glaxosmithkline Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Glaxosmithkline Llc on April 25, 2008. The current certification is valid through July 31, 2018.

What are the primary indications for this medication?

This combination product contains two ingredients: naproxen and sumatriptan. It helps to relieve headache, pain, and other migraine symptoms (including nausea, vomiting, sensitivity to light/sound) in adults and in children 12 years or older. Prompt treatment helps you return to your normal routine and may decrease your need for other pain medications. Naproxen is known as a nonsteroidal anti-inflammatory drug (NSAID). It is used to relieve pain. Sumatriptan belongs to a class of drugs called triptans. It affects a certain natural substance (serotonin) that causes narrowing of blood vessels in the brain. It may also relieve pain by affecting certain nerves in the brain. This medication does not prevent future migraines or lessen how often you get migraine attacks.

How is this Glaxosmithkline Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00173075062. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0173-0750-62
11-Digit CMS (5-4-2)
00173-0750-62

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.